Comparison of the efficacy between concurrent chemoradiotherapy with or without adjuvant chemotherapy for stage II nasopharyngeal carcinoma

BACKGROUND: Although common, the use of concurrent chemoradiotherapy with adjuvant chemotherapy for stage II nasopharyngeal carcinoma (NPC) is controversial due to its undefined clinical benefits. We, therefore, conducted a retrospective cohort study to investigate whether adjuvant chemotherapy conf...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jing, Liu, Tongxin, Sun, Quanquan, Jin, Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373555/
https://www.ncbi.nlm.nih.gov/pubmed/32702809
http://dx.doi.org/10.1097/MD.0000000000020443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373555/
https://www.ncbi.nlm.nih.gov/pubmed/32702809
http://dx.doi.org/10.1097/MD.0000000000020443

Ejemplares similares